{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:25:34Z","timestamp":1779333934811,"version":"3.51.4"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T00:00:00Z","timestamp":1664236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","award":["TSRIRDG6250045"],"award-info":[{"award-number":["TSRIRDG6250045"]}],"id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research and Researchers for Industries","award":["RRIMSD62I0041"],"award-info":[{"award-number":["RRIMSD62I0041"]}]},{"DOI":"10.13039\/501100019253","name":"Mekong Health Science Research Institute, Khon Kaen University","doi-asserted-by":"publisher","award":["MeHSRI09\/2561"],"award-info":[{"award-number":["MeHSRI09\/2561"]}],"id":[{"id":"10.13039\/501100019253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Comorbidity of<jats:italic>Opisthorchis viverrini<\/jats:italic>(OV) infection and nonalcoholic fatty-liver disease (NAFLD) enhances NAFLD progression to nonalcoholic steatohepatitis (NASH) by promoting severe liver inflammation and fibrosis. Here, we investigated the effect of supplementation with curcumin-loaded nanocomplexes (CNCs) on the severity of NASH in hamsters.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methodology<\/jats:title><jats:p>Hamsters were placed in experimental groups as follows: fed standard chow diet (normal control, NC); fed only high-fat and high-fructose (HFF) diet;<jats:italic>O<\/jats:italic>.<jats:italic>viverrini<\/jats:italic>-infected and fed HFF diet (HFFOV); group fed with blank nanocomplexes (HFFOV+BNCs); groups fed different doses of CNCs (25, 50 and 100 mg\/kg body weight: HFFOV+CNCs25; HFFOV+CNCs50; HFFOV+CNCs100, respectively) and a group given native curcumin (HFFOV+CUR). All treatment were for three months.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>The HFF group revealed NAFLD as evidenced by hepatic fat accumulation, ballooning, mild inflammation and little or no fibrosis. These changes were more obvious in the HFFOV group, indicating development of NASH. In contrast, in the HFFOV+CNCs50 group, histopathological features indicated that hepatic fat accumulation, cell ballooning, cell inflammation and fibrosis were lower than in other treatment groups. Relevantly, the expression of lipid-uptake genes, including fatty-acid uptake (cluster of differentiation 36), was reduced, which was associated with the lowering of alanine aminotransferase, total cholesterol and triglyceride (TG) levels. Reduced expression of an inflammation marker (high-mobility group box protein 1) and a fibrosis marker (alpha smooth-muscle actin) were also observed in the HFFOV+CNCs50 group.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>CNCs treatment attenuates the severity of NASH by decreasing hepatic steatosis, inflammation, and fibrosis as well as TG synthesis. CNCs mitigate the severity of NASH in this preclinical study, which indicates promise for future use in patients.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0275273","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T17:30:06Z","timestamp":1664299806000},"page":"e0275273","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Curcumin-loaded nanocomplexes ameliorate the severity of nonalcoholic steatohepatitis in hamsters infected with Opisthorchis viverrini"],"prefix":"10.1371","volume":"17","author":[{"given":"Chutima","family":"Sitthirach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakhanawan","family":"Charoensuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chawalit","family":"Pairojkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-0951","authenticated-orcid":true,"given":"Apisit","family":"Chaidee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitti","family":"Intuyod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thatsanapong","family":"Pongking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phonpilas","family":"Thongpon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanakan","family":"Jantawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuttanan","family":"Hongsrichan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakda","family":"Waraasawapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manachai","family":"Yingklang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-7247","authenticated-orcid":true,"given":"Somchai","family":"Pinlaor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,9,27]]},"reference":[{"key":"pone.0275273.ref001","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"EM Brunt","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"pone.0275273.ref002","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Q Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"pone.0275273.ref003","doi-asserted-by":"crossref","first-page":"101111","DOI":"10.1016\/j.molmet.2020.101111","article-title":"Genetic and epigenetic factors determining NAFLD risk","volume":"50","author":"W Jonas","year":"2021","journal-title":"Mol Metab"},{"key":"pone.0275273.ref004","doi-asserted-by":"crossref","first-page":"691696","DOI":"10.3389\/fmed.2021.691696","article-title":"Is fatty liver associated with depression? a meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease","volume":"8","author":"J Xiao","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"pone.0275273.ref005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5009\/gnl.2012.6.2.149","article-title":"NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications","volume":"6","author":"GC Farrell","year":"2012","journal-title":"Gut and liver"},{"key":"pone.0275273.ref006","doi-asserted-by":"crossref","first-page":"597648","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies","volume":"11","author":"C Luci","year":"2020","journal-title":"Front endocrinol (Lausanne)"},{"issue":"1","key":"pone.0275273.ref007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Z Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"pone.0275273.ref008","doi-asserted-by":"crossref","first-page":"597583","DOI":"10.3389\/fendo.2020.597583","article-title":"Pathophysiology of NAFLD and NASH in experimental models: the role of food intake regulating peptides","volume":"11","author":"L Korinkova","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pone.0275273.ref009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.parint.2011.07.009","article-title":"Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand","volume":"61","author":"E Mairiang","year":"2012","journal-title":"Parasitol Int"},{"issue":"10","key":"pone.0275273.ref010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pt.2012.07.006","article-title":"The tumorigenic liver fluke Opisthorchis viverrini-multiple pathways to cancer","volume":"28","author":"B Sripa","year":"2012","journal-title":"Trends Parasitol"},{"issue":"5","key":"pone.0275273.ref011","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4269\/ajtmh.19-0442","article-title":"Opisthorchis viverrini infection augments the severity of nonalcoholic fatty liver disease in high-fat\/high-fructose diet-fed hamsters","volume":"101","author":"A Chaidee","year":"2019","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pone.0275273.ref012","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40249-019-0529-5","article-title":"Repeated praziquantel treatment and Opisthorchis viverrini infection: a population-based cross-sectional study in northeast Thailand","volume":"8","author":"K Thinkhamrop","year":"2019","journal-title":"Infect Dis Poverty"},{"key":"pone.0275273.ref013","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-015-1475-7","article-title":"Cohort profile: cholangiocarcinoma screening and care program (CASCAP)","volume":"15","author":"N Khuntikeo","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"pone.0275273.ref014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.actatropica.2009.04.011","article-title":"Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection","volume":"111","author":"S Pinlaor","year":"2009","journal-title":"Acta Trop"},{"issue":"4","key":"pone.0275273.ref015","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4269\/ajtmh.2008.78.564","article-title":"Oxidative and nitrative stress in Opisthorchis viverrini-infected hamsters: an indirect effect after praziquantel treatment","volume":"78","author":"S Pinlaor","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"pone.0275273.ref016","doi-asserted-by":"crossref","first-page":"802","DOI":"10.5604\/01.3001.0012.3140","article-title":"Association between repeated praziquantel treatment and papillary, and intrahepatic cholangiocarcinoma","volume":"17","author":"V Luvira","year":"2018","journal-title":"Ann Hepatol"},{"issue":"5","key":"pone.0275273.ref017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052350","article-title":"Treatments for NAFLD: state of art","volume":"22","author":"A Mantovani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0275273.ref018","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fphar.2020.00601","article-title":"Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application","volume":"11","author":"Y Xu","year":"2020","journal-title":"Front Pharmacol"},{"key":"pone.0275273.ref019","doi-asserted-by":"crossref","first-page":"2892917","DOI":"10.1155\/2020\/2892917","article-title":"Curcumin inhibits hepatocellular carcinoma via regulating miR-21\/TIMP3 Axis","volume":"2020","author":"J Li","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"pone.0275273.ref020","doi-asserted-by":"crossref","first-page":"E443","DOI":"10.1208\/aapsj080352","article-title":"Multiple molecular targets in cancer chemoprevention by curcumin","volume":"8","author":"RL Thangapazham","year":"2006","journal-title":"AAPS J"},{"key":"pone.0275273.ref021","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.intimp.2017.01.016","article-title":"Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-kappaB translocation","volume":"44","author":"R Afrin","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"pone.0275273.ref022","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5604\/01.3001.0010.5273","article-title":"Curcumin in hepatobiliary disease: pharmacotherapeutic properties and emerging potential clinical applications","volume":"16","author":"RW Hu","year":"2017","journal-title":"Ann Hepatol"},{"issue":"1","key":"pone.0275273.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11130-016-0590-1","article-title":"Curcumin, a compound from natural sources, a true scientific challenge\u2014a review","volume":"72","author":"Z Stanic","year":"2017","journal-title":"Plant Foods Hum Nutr"},{"issue":"7","key":"pone.0275273.ref024","doi-asserted-by":"crossref","first-page":"e016914","DOI":"10.1136\/bmjopen-2017-016914","article-title":"Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol","volume":"7","author":"SA Jazayeri-Tehrani","year":"2017","journal-title":"BMJ Open"},{"key":"pone.0275273.ref025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12986-019-0331-1","article-title":"Nano-curcumin improves glucose indices, lipids, inflammation, and nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial","volume":"16","author":"SA Jazayeri-Tehrani","year":"2019","journal-title":"Nutr Metab (Lond)"},{"key":"pone.0275273.ref026","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.toxrep.2021.06.021","article-title":"Curcumin-loaded nanocomplexes: acute and chronic toxicity studies in mice and hamsters","volume":"8","author":"C Jantawong","year":"2021","journal-title":"Toxicol Rep"},{"key":"pone.0275273.ref027","doi-asserted-by":"crossref","first-page":"101999","DOI":"10.1016\/j.mtcomm.2020.101999","article-title":"Solid dispersion improves release of curcumin from nanoparticles: potential benefit for intestinal absorption","volume":"26","author":"S Pinlaor","year":"2021","journal-title":"Mater Today Commun"},{"issue":"6","key":"pone.0275273.ref028","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3347\/kjp.2013.51.6.703","article-title":"Distribution and abundance of Opisthorchis viverrini metacercariae in cyprinid fish in Northeastern Thailand","volume":"51","author":"S Pinlaor","year":"2013","journal-title":"Korean J parasitol"},{"issue":"1","key":"pone.0275273.ref029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nano.2015.10.005","article-title":"Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected hamsters","volume":"12","author":"L Charoensuk","year":"2016","journal-title":"Nanomedicine"},{"issue":"3","key":"pone.0275273.ref030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","article-title":"A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer","volume":"65","author":"A Asgharpour","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"pone.0275273.ref031","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"P Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"7 Suppl","key":"pone.0275273.ref032","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"B Thoolen","year":"2010","journal-title":"Toxicol Pathol"},{"issue":"5","key":"pone.0275273.ref033","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cmet.2010.03.012","article-title":"Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency","volume":"11","author":"D Zhang","year":"2010","journal-title":"Cell Metab"},{"issue":"20","key":"pone.0275273.ref034","doi-asserted-by":"crossref","first-page":"25271","DOI":"10.1007\/s11356-020-08941-8","article-title":"Nanocurcumin improved glucose metabolism in streptozotocin-induced diabetic rats: a comparison study with gliclazide","volume":"27","author":"M Afifi","year":"2020","journal-title":"Environ Sci Pollut Res Int"},{"issue":"5","key":"pone.0275273.ref035","first-page":"567","article-title":"The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial","volume":"6","author":"HR Rahimi","year":"2016","journal-title":"Avicenna J Phytomed"},{"key":"pone.0275273.ref036","first-page":"8234507","article-title":"PEGylated curcumin derivative attenuates hepatic steatosis via CREB\/PPAR-gamma\/CD36 pathway","volume":"2017","author":"Y Liu","year":"2017","journal-title":"Biomed Res Int"},{"issue":"14","key":"pone.0275273.ref037","doi-asserted-by":"crossref","first-page":"e13789","DOI":"10.14814\/phy2.13789","article-title":"Curcumin supplementation mitigates NASH development and progression in female Wistar rats","volume":"6","author":"RP Cunningham","year":"2018","journal-title":"Physiol Rep"},{"issue":"7","key":"pone.0275273.ref038","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1194\/jlr.M067397","article-title":"Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance","volume":"57","author":"L Wang","year":"2016","journal-title":"J Lipid Res"},{"issue":"4","key":"pone.0275273.ref039","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Y Kawano","year":"2013","journal-title":"J Gastroenterol"},{"key":"pone.0275273.ref040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"MY Pepino","year":"2014","journal-title":"Annu Rev Nutr"},{"issue":"10","key":"pone.0275273.ref041","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/nu11102536","article-title":"Water extract of Curcuma longa L. ameliorates non-alcoholic fatty liver disease","volume":"11","author":"J Mun","year":"2019","journal-title":"Nutrients"},{"issue":"10","key":"pone.0275273.ref042","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/nu10101553","article-title":"Bioactivity, health benefits, and related molecular mechanisms of curcumin: current progress, challenges, and perspectives","volume":"10","author":"X-Y Xu","year":"2018","journal-title":"Nutrients"},{"key":"pone.0275273.ref043","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.taap.2016.05.011","article-title":"Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway","volume":"304","author":"L Ding","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"pone.0275273.ref044","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01788","article-title":"Role of the sterol regulatory element binding protein pathway in tumorigenesis","volume":"10","author":"T Jiang","year":"2020","journal-title":"Front Oncol"},{"issue":"11","key":"pone.0275273.ref045","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3390\/nu11112702","article-title":"Curcumin ameliorates nonalcoholic fatty liver disease through inhibition of O-GlcNAcylation","volume":"11","author":"DE Lee","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"pone.0275273.ref046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7555\/JBR.27.20120077","article-title":"Lipoprotein metabolism in nonalcoholic fatty liver disease","volume":"27","author":"ZG Jiang","year":"2013","journal-title":"J Biomed Res"},{"key":"pone.0275273.ref047","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"S Wang","year":"2021","journal-title":"J Adv Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0275273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T19:48:46Z","timestamp":1728071326000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0275273"}},"subtitle":[],"editor":[{"given":"Michael W.","family":"Greene","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0275273","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}